UBS Group’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-15,759
| Closed | -$42K | – | 7616 |
|
|
2020
Q1 | $42K | Sell |
15,759
-9,534
| -38% | -$25.4K | ﹤0.01% | 5089 |
|
|
2019
Q4 | $30K | Buy |
25,293
+10,469
| +71% | +$12.4K | ﹤0.01% | 5591 |
|
|
2019
Q3 | $26K | Buy |
14,824
+8,260
| +126% | +$14.5K | ﹤0.01% | 5633 |
|
|
2019
Q2 | $31K | Buy |
6,564
+1,567
| +31% | +$7.4K | ﹤0.01% | 5452 |
|
|
2019
Q1 | $32K | Sell |
4,997
-203
| -4% | -$1.3K | ﹤0.01% | 5085 |
|
|
2018
Q4 | $26K | Buy |
5,200
+3,705
| +248% | +$18.5K | ﹤0.01% | 5689 |
|
|
2018
Q3 | $13K | Buy |
1,495
+1,460
| +4,171% | +$12.7K | ﹤0.01% | 6130 |
|
|
2018
Q2 | $0 | Buy |
+35
| New | – | ﹤0.01% | 7277 |
|